カテゴリー： 世界, 医療/バイオ, QYResearch

ビックテグラビルの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Bictegravir Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10344）・商品コード：QY22JLX10344
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、ビックテグラビルのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にビックテグラビルの世界市場のxxx％を占める「97% - 99%」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ビックテグラビルの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのビックテグラビル市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ビックテグラビルのグローバル主要企業には、Gilead Sciences、Cipla、Laurus Labs、Hetero Drugs Limited、Selleck Chemicals、Shanghai Desano Chemical Pharmaceutical、Shanghai Desano Chemical Pharmaceutical、Changzhou Pharmaceutical Factory、Shanghai Topscience、Jiangsu Coben Pharmaceutical、ShenZhen HwaGen Pharmaceutical、Shanghai Haoyuan Chemexpress、Shanghai Systeam Biochemなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ビックテグラビル市場は、種類と用途によって区分されます。世界のビックテグラビル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
97% - 99%、99%以上

【用途別セグメント】
病院、診療所、研究所

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ビックテグラビル製品概要
- 種類別市場（97% - 99%、99%以上）
- 用途別市場（病院、診療所、研究所）
- 調査の目的
・エグゼクティブサマリー
- 世界のビックテグラビル販売量予測2017-2028
- 世界のビックテグラビル売上予測2017-2028
- ビックテグラビルの地域別販売量
- ビックテグラビルの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ビックテグラビル販売量
- 主要メーカー別ビックテグラビル売上
- 主要メーカー別ビックテグラビル価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（97% - 99%、99%以上）
- ビックテグラビルの種類別販売量
- ビックテグラビルの種類別売上
- ビックテグラビルの種類別価格
・用途別市場規模（病院、診療所、研究所）
- ビックテグラビルの用途別販売量
- ビックテグラビルの用途別売上
- ビックテグラビルの用途別価格
・北米市場
- 北米のビックテグラビル市場規模（種類別、用途別）
- 主要国別のビックテグラビル市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのビックテグラビル市場規模（種類別、用途別）
- 主要国別のビックテグラビル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のビックテグラビル市場規模（種類別、用途別）
- 主要国別のビックテグラビル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のビックテグラビル市場規模（種類別、用途別）
- 主要国別のビックテグラビル市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのビックテグラビル市場規模（種類別、用途別）
- 主要国別のビックテグラビル市場規模（トルコ、サウジアラビア）
・企業情報
Gilead Sciences、Cipla、Laurus Labs、Hetero Drugs Limited、Selleck Chemicals、Shanghai Desano Chemical Pharmaceutical、Shanghai Desano Chemical Pharmaceutical、Changzhou Pharmaceutical Factory、Shanghai Topscience、Jiangsu Coben Pharmaceutical、ShenZhen HwaGen Pharmaceutical、Shanghai Haoyuan Chemexpress、Shanghai Systeam Biochem
・産業チェーン及び販売チャネル分析
- ビックテグラビルの産業チェーン分析
- ビックテグラビルの原材料
- ビックテグラビルの生産プロセス
- ビックテグラビルの販売及びマーケティング
- ビックテグラビルの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ビックテグラビルの産業動向
- ビックテグラビルのマーケットドライバー
- ビックテグラビルの課題
- ビックテグラビルの阻害要因
・主な調査結果

Bictegravir is a potent HIV-1 integrase inhibitor primarily used to treat type 1 AIDS without a history of antiretroviral therapy.
(HIV-1) adult patients, it can also be used as an alternative drug for patients with no history of treatment failure and drug resistance and HIV-1 RNA less than 50copies/ml.
Market Analysis and Insights: Global Bictegravir Market
Due to the COVID-19 pandemic, the global Bictegravir market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 97% – 99% accounting for % of the Bictegravir global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Bictegravir market size is valued at US$ million in 2021, while the US and Europe Bictegravir are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bictegravir landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Bictegravir include Gilead Sciences, Cipla, Laurus Labs, Hetero Drugs Limited, Selleck Chemicals, Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical, Changzhou Pharmaceutical Factory, Shanghai Topscience and Jiangsu Coben Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Bictegravir Scope and Segment
Bictegravir market is segmented by Purity and by Application. Players, stakeholders, and other participants in the global Bictegravir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Purity and by Application for the period 2017-2028.
Segment by Purity
97% – 99%
Above 99%
Segment by Application
Hospitals
Clinics
Labs
By Company
Gilead Sciences
Cipla
Laurus Labs
Hetero Drugs Limited
Selleck Chemicals
Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical
Changzhou Pharmaceutical Factory
Shanghai Topscience
Jiangsu Coben Pharmaceutical
ShenZhen HwaGen Pharmaceutical
Shanghai Haoyuan Chemexpress
Shanghai Systeam Biochem
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Bictegravir Product Introduction
1.2 Market by Purity
1.2.1 Global Bictegravir Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028
1.2.2 97% – 99%
1.2.3 Above 99%
1.3 Market by Application
1.3.1 Global Bictegravir Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Labs
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bictegravir Sales Estimates and Forecasts 2017-2028
2.2 Global Bictegravir Revenue Estimates and Forecasts 2017-2028
2.3 Global Bictegravir Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bictegravir Sales by Region
2.4.1 Global Bictegravir Sales by Region (2017-2022)
2.4.2 Global Sales Bictegravir by Region (2023-2028)
2.5 Global Bictegravir Revenue by Region
2.5.1 Global Bictegravir Revenue by Region (2017-2022)
2.5.2 Global Bictegravir Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bictegravir Sales by Manufacturers
3.1.1 Global Top Bictegravir Manufacturers by Sales (2017-2022)
3.1.2 Global Bictegravir Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bictegravir in 2021
3.2 Global Bictegravir Revenue by Manufacturers
3.2.1 Global Bictegravir Revenue by Manufacturers (2017-2022)
3.2.2 Global Bictegravir Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bictegravir Revenue in 2021
3.3 Global Bictegravir Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bictegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bictegravir Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Purity
4.1 Global Bictegravir Sales by Purity
4.1.1 Global Bictegravir Historical Sales by Purity (2017-2022)
4.1.2 Global Bictegravir Forecasted Sales by Purity (2023-2028)
4.1.3 Global Bictegravir Sales Market Share by Purity (2017-2028)
4.2 Global Bictegravir Revenue by Purity
4.2.1 Global Bictegravir Historical Revenue by Purity (2017-2022)
4.2.2 Global Bictegravir Forecasted Revenue by Purity (2023-2028)
4.2.3 Global Bictegravir Revenue Market Share by Purity (2017-2028)
4.3 Global Bictegravir Price by Purity
4.3.1 Global Bictegravir Price by Purity (2017-2022)
4.3.2 Global Bictegravir Price Forecast by Purity (2023-2028)
5 Market Size by Application
5.1 Global Bictegravir Sales by Application
5.1.1 Global Bictegravir Historical Sales by Application (2017-2022)
5.1.2 Global Bictegravir Forecasted Sales by Application (2023-2028)
5.1.3 Global Bictegravir Sales Market Share by Application (2017-2028)
5.2 Global Bictegravir Revenue by Application
5.2.1 Global Bictegravir Historical Revenue by Application (2017-2022)
5.2.2 Global Bictegravir Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bictegravir Revenue Market Share by Application (2017-2028)
5.3 Global Bictegravir Price by Application
5.3.1 Global Bictegravir Price by Application (2017-2022)
5.3.2 Global Bictegravir Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bictegravir Market Size by Purity
6.1.1 North America Bictegravir Sales by Purity (2017-2028)
6.1.2 North America Bictegravir Revenue by Purity (2017-2028)
6.2 North America Bictegravir Market Size by Application
6.2.1 North America Bictegravir Sales by Application (2017-2028)
6.2.2 North America Bictegravir Revenue by Application (2017-2028)
6.3 North America Bictegravir Market Size by Country
6.3.1 North America Bictegravir Sales by Country (2017-2028)
6.3.2 North America Bictegravir Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Bictegravir Market Size by Purity
7.1.1 Europe Bictegravir Sales by Purity (2017-2028)
7.1.2 Europe Bictegravir Revenue by Purity (2017-2028)
7.2 Europe Bictegravir Market Size by Application
7.2.1 Europe Bictegravir Sales by Application (2017-2028)
7.2.2 Europe Bictegravir Revenue by Application (2017-2028)
7.3 Europe Bictegravir Market Size by Country
7.3.1 Europe Bictegravir Sales by Country (2017-2028)
7.3.2 Europe Bictegravir Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bictegravir Market Size by Purity
8.1.1 Asia Pacific Bictegravir Sales by Purity (2017-2028)
8.1.2 Asia Pacific Bictegravir Revenue by Purity (2017-2028)
8.2 Asia Pacific Bictegravir Market Size by Application
8.2.1 Asia Pacific Bictegravir Sales by Application (2017-2028)
8.2.2 Asia Pacific Bictegravir Revenue by Application (2017-2028)
8.3 Asia Pacific Bictegravir Market Size by Region
8.3.1 Asia Pacific Bictegravir Sales by Region (2017-2028)
8.3.2 Asia Pacific Bictegravir Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Bictegravir Market Size by Purity
9.1.1 Latin America Bictegravir Sales by Purity (2017-2028)
9.1.2 Latin America Bictegravir Revenue by Purity (2017-2028)
9.2 Latin America Bictegravir Market Size by Application
9.2.1 Latin America Bictegravir Sales by Application (2017-2028)
9.2.2 Latin America Bictegravir Revenue by Application (2017-2028)
9.3 Latin America Bictegravir Market Size by Country
9.3.1 Latin America Bictegravir Sales by Country (2017-2028)
9.3.2 Latin America Bictegravir Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Bictegravir Market Size by Purity
10.1.1 Middle East and Africa Bictegravir Sales by Purity (2017-2028)
10.1.2 Middle East and Africa Bictegravir Revenue by Purity (2017-2028)
10.2 Middle East and Africa Bictegravir Market Size by Application
10.2.1 Middle East and Africa Bictegravir Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bictegravir Revenue by Application (2017-2028)
10.3 Middle East and Africa Bictegravir Market Size by Country
10.3.1 Middle East and Africa Bictegravir Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bictegravir Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Corporation Information
11.1.2 Gilead Sciences Overview
11.1.3 Gilead Sciences Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Gilead Sciences Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Gilead Sciences Recent Developments
11.2 Cipla
11.2.1 Cipla Corporation Information
11.2.2 Cipla Overview
11.2.3 Cipla Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cipla Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cipla Recent Developments
11.3 Laurus Labs
11.3.1 Laurus Labs Corporation Information
11.3.2 Laurus Labs Overview
11.3.3 Laurus Labs Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Laurus Labs Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Laurus Labs Recent Developments
11.4 Hetero Drugs Limited
11.4.1 Hetero Drugs Limited Corporation Information
11.4.2 Hetero Drugs Limited Overview
11.4.3 Hetero Drugs Limited Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hetero Drugs Limited Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hetero Drugs Limited Recent Developments
11.5 Selleck Chemicals
11.5.1 Selleck Chemicals Corporation Information
11.5.2 Selleck Chemicals Overview
11.5.3 Selleck Chemicals Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Selleck Chemicals Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Selleck Chemicals Recent Developments
11.6 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical
11.6.1 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Corporation Information
11.6.2 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Overview
11.6.3 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Recent Developments
11.7 Changzhou Pharmaceutical Factory
11.7.1 Changzhou Pharmaceutical Factory Corporation Information
11.7.2 Changzhou Pharmaceutical Factory Overview
11.7.3 Changzhou Pharmaceutical Factory Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Changzhou Pharmaceutical Factory Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Changzhou Pharmaceutical Factory Recent Developments
11.8 Shanghai Topscience
11.8.1 Shanghai Topscience Corporation Information
11.8.2 Shanghai Topscience Overview
11.8.3 Shanghai Topscience Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Shanghai Topscience Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shanghai Topscience Recent Developments
11.9 Jiangsu Coben Pharmaceutical
11.9.1 Jiangsu Coben Pharmaceutical Corporation Information
11.9.2 Jiangsu Coben Pharmaceutical Overview
11.9.3 Jiangsu Coben Pharmaceutical Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Jiangsu Coben Pharmaceutical Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jiangsu Coben Pharmaceutical Recent Developments
11.10 ShenZhen HwaGen Pharmaceutical
11.10.1 ShenZhen HwaGen Pharmaceutical Corporation Information
11.10.2 ShenZhen HwaGen Pharmaceutical Overview
11.10.3 ShenZhen HwaGen Pharmaceutical Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 ShenZhen HwaGen Pharmaceutical Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 ShenZhen HwaGen Pharmaceutical Recent Developments
11.11 Shanghai Haoyuan Chemexpress
11.11.1 Shanghai Haoyuan Chemexpress Corporation Information
11.11.2 Shanghai Haoyuan Chemexpress Overview
11.11.3 Shanghai Haoyuan Chemexpress Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shanghai Haoyuan Chemexpress Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai Haoyuan Chemexpress Recent Developments
11.12 Shanghai Systeam Biochem
11.12.1 Shanghai Systeam Biochem Corporation Information
11.12.2 Shanghai Systeam Biochem Overview
11.12.3 Shanghai Systeam Biochem Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shanghai Systeam Biochem Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shanghai Systeam Biochem Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bictegravir Industry Chain Analysis
12.2 Bictegravir Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bictegravir Production Mode & Process
12.4 Bictegravir Sales and Marketing
12.4.1 Bictegravir Sales Channels
12.4.2 Bictegravir Distributors
12.5 Bictegravir Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bictegravir Industry Trends
13.2 Bictegravir Market Drivers
13.3 Bictegravir Market Challenges
13.4 Bictegravir Market Restraints
14 Key Findings in The Global Bictegravir Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Bictegravir Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 97% - 99%
Table 3. Major Manufacturers of Above 99%
Table 4. Global Bictegravir Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Bictegravir Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Bictegravir Sales by Region (2017-2022) & (Tons)
Table 7. Global Bictegravir Sales Market Share by Region (2017-2022)
Table 8. Global Bictegravir Sales by Region (2023-2028) & (Tons)
Table 9. Global Bictegravir Sales Market Share by Region (2023-2028)
Table 10. Global Bictegravir Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Bictegravir Revenue Market Share by Region (2017-2022)
Table 12. Global Bictegravir Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Bictegravir Revenue Market Share by Region (2023-2028)
Table 14. Global Bictegravir Sales by Manufacturers (2017-2022) & (Tons)
Table 15. Global Bictegravir Sales Share by Manufacturers (2017-2022)
Table 16. Global Bictegravir Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Bictegravir Revenue Share by Manufacturers (2017-2022)
Table 18. Bictegravir Price by Manufacturers (2017-2022) &(K US$/Ton)
Table 19. Global Bictegravir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Bictegravir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bictegravir as of 2021)
Table 21. Bictegravir Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Bictegravir Product Offered
Table 23. Date of Manufacturers Enter into Bictegravir Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bictegravir Sales by Purity (2017-2022) & (Tons)
Table 26. Global Bictegravir Sales by Purity (2023-2028) & (Tons)
Table 27. Global Bictegravir Sales Share by Purity (2017-2022)
Table 28. Global Bictegravir Sales Share by Purity (2023-2028)
Table 29. Global Bictegravir Revenue by Purity (2017-2022) & (US$ Million)
Table 30. Global Bictegravir Revenue by Purity (2023-2028) & (US$ Million)
Table 31. Global Bictegravir Revenue Share by Purity (2017-2022)
Table 32. Global Bictegravir Revenue Share by Purity (2023-2028)
Table 33. Bictegravir Price by Purity (2017-2022) & (K US$/Ton)
Table 34. Global Bictegravir Price Forecast by Purity (2023-2028) & (K US$/Ton)
Table 35. Global Bictegravir Sales by Application (2017-2022) & (Tons)
Table 36. Global Bictegravir Sales by Application (2023-2028) & (Tons)
Table 37. Global Bictegravir Sales Share by Application (2017-2022)
Table 38. Global Bictegravir Sales Share by Application (2023-2028)
Table 39. Global Bictegravir Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Bictegravir Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Bictegravir Revenue Share by Application (2017-2022)
Table 42. Global Bictegravir Revenue Share by Application (2023-2028)
Table 43. Bictegravir Price by Application (2017-2022) & (K US$/Ton)
Table 44. Global Bictegravir Price Forecast by Application (2023-2028) & (K US$/Ton)
Table 45. North America Bictegravir Sales by Purity (2017-2022) & (Tons)
Table 46. North America Bictegravir Sales by Purity (2023-2028) & (Tons)
Table 47. North America Bictegravir Revenue by Purity (2017-2022) & (US$ Million)
Table 48. North America Bictegravir Revenue by Purity (2023-2028) & (US$ Million)
Table 49. North America Bictegravir Sales by Application (2017-2022) & (Tons)
Table 50. North America Bictegravir Sales by Application (2023-2028) & (Tons)
Table 51. North America Bictegravir Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Bictegravir Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Bictegravir Sales by Country (2017-2022) & (Tons)
Table 54. North America Bictegravir Sales by Country (2023-2028) & (Tons)
Table 55. North America Bictegravir Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Bictegravir Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Bictegravir Sales by Purity (2017-2022) & (Tons)
Table 58. Europe Bictegravir Sales by Purity (2023-2028) & (Tons)
Table 59. Europe Bictegravir Revenue by Purity (2017-2022) & (US$ Million)
Table 60. Europe Bictegravir Revenue by Purity (2023-2028) & (US$ Million)
Table 61. Europe Bictegravir Sales by Application (2017-2022) & (Tons)
Table 62. Europe Bictegravir Sales by Application (2023-2028) & (Tons)
Table 63. Europe Bictegravir Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Bictegravir Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Bictegravir Sales by Country (2017-2022) & (Tons)
Table 66. Europe Bictegravir Sales by Country (2023-2028) & (Tons)
Table 67. Europe Bictegravir Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Bictegravir Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Bictegravir Sales by Purity (2017-2022) & (Tons)
Table 70. Asia Pacific Bictegravir Sales by Purity (2023-2028) & (Tons)
Table 71. Asia Pacific Bictegravir Revenue by Purity (2017-2022) & (US$ Million)
Table 72. Asia Pacific Bictegravir Revenue by Purity (2023-2028) & (US$ Million)
Table 73. Asia Pacific Bictegravir Sales by Application (2017-2022) & (Tons)
Table 74. Asia Pacific Bictegravir Sales by Application (2023-2028) & (Tons)
Table 75. Asia Pacific Bictegravir Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Bictegravir Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Bictegravir Sales by Region (2017-2022) & (Tons)
Table 78. Asia Pacific Bictegravir Sales by Region (2023-2028) & (Tons)
Table 79. Asia Pacific Bictegravir Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Bictegravir Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Bictegravir Sales by Purity (2017-2022) & (Tons)
Table 82. Latin America Bictegravir Sales by Purity (2023-2028) & (Tons)
Table 83. Latin America Bictegravir Revenue by Purity (2017-2022) & (US$ Million)
Table 84. Latin America Bictegravir Revenue by Purity (2023-2028) & (US$ Million)
Table 85. Latin America Bictegravir Sales by Application (2017-2022) & (Tons)
Table 86. Latin America Bictegravir Sales by Application (2023-2028) & (Tons)
Table 87. Latin America Bictegravir Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Bictegravir Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Bictegravir Sales by Country (2017-2022) & (Tons)
Table 90. Latin America Bictegravir Sales by Country (2023-2028) & (Tons)
Table 91. Latin America Bictegravir Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Bictegravir Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Bictegravir Sales by Purity (2017-2022) & (Tons)
Table 94. Middle East and Africa Bictegravir Sales by Purity (2023-2028) & (Tons)
Table 95. Middle East and Africa Bictegravir Revenue by Purity (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Bictegravir Revenue by Purity (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Bictegravir Sales by Application (2017-2022) & (Tons)
Table 98. Middle East and Africa Bictegravir Sales by Application (2023-2028) & (Tons)
Table 99. Middle East and Africa Bictegravir Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Bictegravir Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Bictegravir Sales by Country (2017-2022) & (Tons)
Table 102. Middle East and Africa Bictegravir Sales by Country (2023-2028) & (Tons)
Table 103. Middle East and Africa Bictegravir Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Bictegravir Revenue by Country (2023-2028) & (US$ Million)
Table 105. Gilead Sciences Corporation Information
Table 106. Gilead Sciences Description and Major Businesses
Table 107. Gilead Sciences Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 108. Gilead Sciences Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Gilead Sciences Recent Developments
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Major Businesses
Table 112. Cipla Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 113. Cipla Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Cipla Recent Developments
Table 115. Laurus Labs Corporation Information
Table 116. Laurus Labs Description and Major Businesses
Table 117. Laurus Labs Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 118. Laurus Labs Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Laurus Labs Recent Developments
Table 120. Hetero Drugs Limited Corporation Information
Table 121. Hetero Drugs Limited Description and Major Businesses
Table 122. Hetero Drugs Limited Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 123. Hetero Drugs Limited Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Hetero Drugs Limited Recent Developments
Table 125. Selleck Chemicals Corporation Information
Table 126. Selleck Chemicals Description and Major Businesses
Table 127. Selleck Chemicals Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 128. Selleck Chemicals Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Selleck Chemicals Recent Developments
Table 130. Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Corporation Information
Table 131. Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Description and Major Businesses
Table 132. Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 133. Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Recent Developments
Table 135. Changzhou Pharmaceutical Factory Corporation Information
Table 136. Changzhou Pharmaceutical Factory Description and Major Businesses
Table 137. Changzhou Pharmaceutical Factory Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 138. Changzhou Pharmaceutical Factory Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Changzhou Pharmaceutical Factory Recent Developments
Table 140. Shanghai Topscience Corporation Information
Table 141. Shanghai Topscience Description and Major Businesses
Table 142. Shanghai Topscience Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 143. Shanghai Topscience Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Shanghai Topscience Recent Developments
Table 145. Jiangsu Coben Pharmaceutical Corporation Information
Table 146. Jiangsu Coben Pharmaceutical Description and Major Businesses
Table 147. Jiangsu Coben Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 148. Jiangsu Coben Pharmaceutical Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Jiangsu Coben Pharmaceutical Recent Developments
Table 150. ShenZhen HwaGen Pharmaceutical Corporation Information
Table 151. ShenZhen HwaGen Pharmaceutical Description and Major Businesses
Table 152. ShenZhen HwaGen Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 153. ShenZhen HwaGen Pharmaceutical Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. ShenZhen HwaGen Pharmaceutical Recent Developments
Table 155. Shanghai Haoyuan Chemexpress Corporation Information
Table 156. Shanghai Haoyuan Chemexpress Description and Major Businesses
Table 157. Shanghai Haoyuan Chemexpress Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 158. Shanghai Haoyuan Chemexpress Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Shanghai Haoyuan Chemexpress Recent Developments
Table 160. Shanghai Systeam Biochem Corporation Information
Table 161. Shanghai Systeam Biochem Description and Major Businesses
Table 162. Shanghai Systeam Biochem Bictegravir Sales (Tons), Revenue (US$ Million), Price (K US$/Ton) and Gross Margin (2017-2022)
Table 163. Shanghai Systeam Biochem Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Shanghai Systeam Biochem Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Bictegravir Distributors List
Table 168. Bictegravir Customers List
Table 169. Bictegravir Market Trends
Table 170. Bictegravir Market Drivers
Table 171. Bictegravir Market Challenges
Table 172. Bictegravir Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Bictegravir Product Picture
Figure 3. Global Bictegravir Market Share by Purity in 2021 & 2028
Figure 3. 97% - 99% Product Picture
Figure 4. Above 99% Product Picture
Figure 5. Global Bictegravir Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Labs
Figure 9. Bictegravir Report Years Considered
Figure 10. Global Bictegravir Sales 2017-2028 (Tons)
Figure 11. Global Bictegravir Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Bictegravir Revenue 2017-2028 (US$ Million)
Figure 13. Global Bictegravir Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Bictegravir Sales Market Share by Region (2017-2022)
Figure 15. Global Bictegravir Sales Market Share by Region (2023-2028)
Figure 16. North America Bictegravir Sales YoY (2017-2028) & (Tons)
Figure 17. North America Bictegravir Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Bictegravir Sales YoY (2017-2028) & (Tons)
Figure 19. Europe Bictegravir Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Bictegravir Sales YoY (2017-2028) & (Tons)
Figure 21. Asia-Pacific Bictegravir Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Bictegravir Sales YoY (2017-2028) & (Tons)
Figure 23. Latin America Bictegravir Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Bictegravir Sales YoY (2017-2028) & (Tons)
Figure 25. Middle East & Africa Bictegravir Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Bictegravir Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Bictegravir in the World: Market Share by Bictegravir Revenue in 2021
Figure 28. Global Bictegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Bictegravir Sales Market Share by Purity (2017-2028)
Figure 30. Global Bictegravir Revenue Market Share by Purity (2017-2028)
Figure 31. Global Bictegravir Sales Market Share by Application (2017-2028)
Figure 32. Global Bictegravir Revenue Market Share by Application (2017-2028)
Figure 33. North America Bictegravir Sales Market Share by Purity (2017-2028)
Figure 34. North America Bictegravir Revenue Market Share by Purity (2017-2028)
Figure 35. North America Bictegravir Sales Market Share by Application (2017-2028)
Figure 36. North America Bictegravir Revenue Market Share by Application (2017-2028)
Figure 37. North America Bictegravir Sales Share by Country (2017-2028)
Figure 38. North America Bictegravir Revenue Share by Country (2017-2028)
Figure 39. United States Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Bictegravir Sales Market Share by Purity (2017-2028)
Figure 42. Europe Bictegravir Revenue Market Share by Purity (2017-2028)
Figure 43. Europe Bictegravir Sales Market Share by Application (2017-2028)
Figure 44. Europe Bictegravir Revenue Market Share by Application (2017-2028)
Figure 45. Europe Bictegravir Sales Share by Country (2017-2028)
Figure 46. Europe Bictegravir Revenue Share by Country (2017-2028)
Figure 47. Germany Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 48. France Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Bictegravir Sales Market Share by Purity (2017-2028)
Figure 53. Asia Pacific Bictegravir Revenue Market Share by Purity (2017-2028)
Figure 54. Asia Pacific Bictegravir Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Bictegravir Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Bictegravir Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Bictegravir Revenue Share by Region (2017-2028)
Figure 58. China Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 61. India Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Bictegravir Sales Market Share by Purity (2017-2028)
Figure 68. Latin America Bictegravir Revenue Market Share by Purity (2017-2028)
Figure 69. Latin America Bictegravir Sales Market Share by Application (2017-2028)
Figure 70. Latin America Bictegravir Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Bictegravir Sales Share by Country (2017-2028)
Figure 72. Latin America Bictegravir Revenue Share by Country (2017-2028)
Figure 73. Mexico Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Bictegravir Sales Market Share by Purity (2017-2028)
Figure 78. Middle East and Africa Bictegravir Revenue Market Share by Purity (2017-2028)
Figure 79. Middle East and Africa Bictegravir Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Bictegravir Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Bictegravir Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Bictegravir Revenue Share by Country (2017-2028)
Figure 83. Turkey Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Bictegravir Revenue (2017-2028) & (US$ Million)
Figure 86. Bictegravir Value Chain
Figure 87. Bictegravir Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed


★調査レポート[ビックテグラビルの世界市場インサイト・予測（～2028年）] (コード：QY22JLX10344)販売に関する免責事項を必ずご確認ください。
★調査レポート[ビックテグラビルの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 高純度リドカインの世界市場インサイト・予測（～2028年）
  • D-カンファースルホン酸の世界市場インサイト・予測（～2028年）
  • 2-メチル-5-ニトロイミダゾールの世界市場インサイト・予測（～2028年）
  • 高純度アルシン・ホスフィンの世界市場インサイト・予測（～2028年）
  • 高純度アルキル化剤の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆